Business Description
Alligator Bioscience AB
ISIN : SE0000767188
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.11 | |||||
Equity-to-Asset | 0.1 | |||||
Debt-to-Equity | 1.36 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -15.62 | |||||
Beneish M-Score | -4.97 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 52 | |||||
3-Year EBITDA Growth Rate | 22 | |||||
3-Year EPS without NRI Growth Rate | 23.3 | |||||
3-Year FCF Growth Rate | 29.1 | |||||
3-Year Book Growth Rate | -72.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.44 | |||||
9-Day RSI | 32.32 | |||||
14-Day RSI | 37.39 | |||||
6-1 Month Momentum % | 221.83 | |||||
12-1 Month Momentum % | 66.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.79 | |||||
Quick Ratio | 0.79 | |||||
Cash Ratio | 0.67 | |||||
Days Sales Outstanding | 53.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -69.9 | |||||
Shareholder Yield % | -28.36 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -429.19 | |||||
Net Margin % | -427.81 | |||||
FCF Margin % | -332.8 | |||||
ROE % | -375.32 | |||||
ROA % | -151.92 | |||||
ROIC % | -214.38 | |||||
ROC (Joel Greenblatt) % | -1015.13 | |||||
ROCE % | -317.92 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.98 | |||||
PB Ratio | 50 | |||||
EV-to-EBIT | -2.55 | |||||
EV-to-EBITDA | -2.66 | |||||
EV-to-Revenue | 10.88 | |||||
EV-to-FCF | -3.3 | |||||
Earnings Yield (Greenblatt) % | -39.22 | |||||
FCF Yield % | -28.11 |